Log In
Print
BCIQ
Print
Print this Print this
 

PRT060318

  Manage Alerts
Collapse Summary General Information
Company Portola Pharmaceuticals Inc.
DescriptionSmall molecule spleen tyrosine kinase (SYK) inhibitor
Molecular Target Spleen tyrosine kinase (SYK)
Mechanism of Action 
Latest Stage of DevelopmentPreclinical
IndicationAcute lymphoblastic leukemia (ALL)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today